We are live on ! Find out more
MIG

Mariner Investment Group Portfolio holdings

AUM $463M
1-Year Est. Return 13.33%
This Fund
S&P 500
This Quarter Est. Return
-2.1%
1 Year Est. Return
+13.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$391M
AUM Growth
+$18.6M
Cap. Flow
+$404M
Cap. Flow %
103.39%
Top 10 Hldgs %
23.32%
Holding
264
New
87
Increased
59
Reduced
44
Closed
52

Sector Composition

Rank Sector Weight
1 Healthcare 26.75%
2 Real Estate 4.27%
3 Financials 2.79%
4 Materials 0.65%
5 Communication Services 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCV
101
Virtus Convertible & Income Fund
NCV
$378M
$1.21M 0.31%
+37,200
New +$1.32M
ELGX
102
DELISTED
Endologix Inc
ELGX
$1.18M 0.3%
7,720
ARIA
103
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.18M 0.3%
142,800
-47,500
-25% -$420K
PBYI icon
104
Puma Biotechnology
PBYI
$404M
$1.17M 0.3%
+10,000
New +$1.81M
A icon
105
Agilent Technologies
A
$39.1B
$1.16M 0.3%
30,000
+10,000
+50% +$415K
ADVM
106
DELISTED
Adverum Biotechnologies
ADVM
$1.12M 0.29%
6,900
+5,400
+360% +$1.82M
PDI icon
107
PIMCO Dynamic Income Fund
PDI
$7.39B
$1.06M 0.27%
+36,400
New +$1.08M
MRK icon
108
Merck
MRK
$322B
$1.05M 0.27%
+19,388
New +$1.09M
MNK
109
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.03M 0.26%
8,777
-10,000
-53% -$1.23M
XENT
110
DELISTED
Intersect ENT, Inc
XENT
$1.01M 0.26%
35,213
DYAX
111
DELISTED
DYAX CORPORATION
DYAX
$954K 0.24%
+36,000
New +$954K
ATYR
112
aTyr Pharma
ATYR
$47.6M
$938K 0.24%
+3,619
New +$1.12M
TMO icon
113
Thermo Fisher Scientific
TMO
$213B
$908K 0.23%
7,000
KIO
114
KKR Income Opportunities Fund
KIO
$451M
$907K 0.23%
+57,554
New +$936K
DBA icon
115
Invesco DB Agriculture Fund
DBA
$1.23B
$817K 0.21%
+35,000
New +$780K
IRWD icon
116
Ironwood Pharmaceuticals
IRWD
$696M
$807K 0.21%
79,879
+3,941
+5% +$45.8K
XLRN
117
DELISTED
Acceleron Pharma
XLRN
$785K 0.2%
+24,800
New +$800K
KITE
118
DELISTED
Kite Pharma, Inc.
KITE
$763K 0.2%
12,507
+500
+4% +$28.5K
TLT icon
119
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$737K 0.19%
+327,800
New +$40.2M
MACK
120
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$706K 0.18%
+7,256
New +$690K
LMNX
121
DELISTED
Luminex Corp
LMNX
$702K 0.18%
40,700
+20,000
+97% +$335K
PCM
122
PCM Fund
PCM
$69.3M
$698K 0.18%
+69,417
New +$732K
VTRS icon
123
Viatris
VTRS
$20.4B
$679K 0.17%
10,000
+4,000
+67% +$283K
ARMF
124
DELISTED
ARES MULTI-STRATEGY CR FD INC COM STK (MD)
ARMF
$679K 0.17%
+36,092
New +$716K
BLUE
125
DELISTED
bluebird bio
BLUE
$673K 0.17%
309
-77
-20% -$157K

Similar funds

Mariner Investment Group's Q2 2015 Portfolio in Review

As of Q2 2015, Mariner Investment Group held 264 positions worth $391M, up 5% from $372M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Mariner Investment Group deployed $404M of net new capital in Q2 2015, opening 87 new positions and adding to 59 existing holdings. Its largest new stake was CENTRAL GOLD TR (CANADA): 146,017 shares worth $6M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 23% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was Diversified Real Asset Income Fd, an estimated $3.93M trimmed.

  • Mariner Investment Group's largest Q2 2015 buy was CENTRAL GOLD TR (CANADA): 146,017 shares worth $6M.
  • Mariner Investment Group added most to Liberty All-Star Equity Fund in Q2 2015, an estimated $5.84M increase.
  • Mariner Investment Group's biggest Q2 2015 reduction was Diversified Real Asset Income Fd, cutting an estimated $3.93M.
  • Mariner Investment Group fully exited NEXPOINT CREDIT STRATEGIES FUND in Q2 2015, selling an estimated $12.6M.
  • Mariner Investment Group's ten largest holdings make up 23% of its $391M portfolio in Q2 2015.
  • Mariner Investment Group opened 87 new positions and closed 52 in Q2 2015.
  • Mariner Investment Group's portfolio value rose 5% quarter-over-quarter to $391M.

Based on Mariner Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.